CC0000: Color is not claimed as a feature of the mark.
D10000: "PHARMACEUTICALS"
DM0000: The mark consists of the words "EPIGENESIS PHARMACEUTICALS" and two stylized versions of the letter "E", one facing right and one facing left.
GS0051: medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (SVT), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate
Case File Event Statements
6/20/2011 - 13 years ago
29 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDType:MAB6
6/20/2011 - 13 years ago
28 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
5/5/2011 - 13 years ago
27 - WITHDRAWAL OF ATTORNEY GRANTEDType:WOAG
5/5/2011 - 13 years ago
26 - TEAS WITHDRAWAL OF ATTORNEY RECEIVEDType:WOAR
11/6/2010 - 14 years ago
25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
11/5/2010 - 14 years ago
24 - EXTENSION 3 GRANTEDType:EX3G
11/4/2010 - 14 years ago
23 - EXTENSION 3 FILEDType:EXT3
11/4/2010 - 14 years ago
22 - TEAS EXTENSION RECEIVEDType:EEXT
6/4/2010 - 14 years ago
21 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
6/3/2010 - 14 years ago
20 - EXTENSION 2 GRANTEDType:EX2G
5/17/2010 - 14 years ago
19 - EXTENSION 2 FILEDType:EXT2
6/3/2010 - 14 years ago
18 - CASE ASSIGNED TO INTENT TO USE PARALEGALType:AITU
5/17/2010 - 14 years ago
17 - TEAS EXTENSION RECEIVEDType:EEXT
11/3/2009 - 15 years ago
16 - EXTENSION 1 GRANTEDType:EX1G
11/3/2009 - 15 years ago
15 - EXTENSION 1 FILEDType:EXT1
11/3/2009 - 15 years ago
14 - TEAS EXTENSION RECEIVEDType:EEXT
5/19/2009 - 15 years ago
13 - NOA MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
2/24/2009 - 15 years ago
12 - PUBLISHED FOR OPPOSITIONType:PUBO
2/4/2009 - 15 years ago
11 - NOTICE OF PUBLICATIONType:NPUB
1/22/2009 - 15 years ago
10 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
1/22/2009 - 15 years ago
9 - ASSIGNED TO LIEType:ALIE
1/6/2009 - 15 years ago
8 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
1/6/2009 - 15 years ago
7 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
1/6/2009 - 15 years ago
6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN